Home › Atrial Fibrillation › Alabama
Atrial Fibrillation clinical trials in Alabama
11 studies for Atrial Fibrillation are looking for participants at sites in Alabama.
Cities in Alabama
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Advanced Cardiovascular, Alexander City
- SEC Clinical Research, Dothan
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- SEC Clinical Research, Dothan
- Eastern Shore Research Institute, Fairhope
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07175428A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Grandview Medical Center, Birmingham
Recruiting
Ages 18 to 80 · All sexes · Updated Sep 25, 2026 · NCT07527299Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- University of Alabama at Birmingham, Birmingham
- Grandview Medical Center, Birmingham
- Cardiology Associates of Mobile, Mobile
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- SEC Clinical Research, Dothan
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07430956Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- University of Alabama at Birmingham (UAB) Hospital, Birmingham
Recruiting
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07298473Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Grandview, Birmingham
Recruiting
Ages 18 to 80 · All sexes · Updated Jul 15, 2026 · NCT06784466Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1040, Birmingham
- Anthos Investigational site 9939, Birmingham
- Anthos Investigative Site 9947, Birmingham
- and 1 more
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Tracking Results of Ablations to Combat AF Registry Generation 2
- Huntsville Hospital, Huntsville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05111015Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- University of Alabama Hospital, Birmingham
- University of South Alabama University Hospital, Mobile
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
- Arrhythmia Institute at Grandview, Birmingham
- Mobile Cardiology Associates, Mobile
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 31, 2025 · NCT06324201From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.